Cian Healthcare Ltd (CHCL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Cian Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
As per the Attachment.
Others (Uncategorized) · 24 Oct 2026, 1:46 am
Cian Healthcare Subsidiary Dr. Smiths Biotech Ceases Operations Following NCLT Resolution Plan NCLT Mumbai approved the resolution plan submitted by Ananta Medicare for Cian Healthcare's wholly owned subsidiary, Dr. Smiths Biotech, leading to the complete extinguishment of its equity share capital effective 23rd Oct'26. Consequently, Dr. Smiths ceased to be a subsidiary, with Cian receiving nil consideration. In FY25-26, Dr. Smiths contributed zero operational revenue, ₹1.03 lakhs (0.03%) in total income, and a negative net worth of ₹(987.00) lakhs to Cian's consolidated financials. Resolution applicant Ananta Medicare is a holding company and promoter of Cian Healthcare.
As per the Attachment.
Annual General Meeting · 30 Sept 2026, 12:02 am
Cian Healthcare Shareholders Approve FY26 Results, Auditor Appointments, and ESOP Scheme Cian Healthcare Limited concluded its 23rd AGM on 29th Sep'26, with all six resolutions passed with 100% approval of polled votes. Key ordinary approvals include adopting FY26 audited standalone and consolidated financial statements, re-appointing Non-Executive Director Mr. Pradeep Kumar Jain, and appointing M/s Rasool Singhal & Co., Chartered Accountants, as statutory auditors. Special resolutions were passed approving the Employee Stock Option Scheme 2026 and extending option grants to eligible employees across group companies, subsidiaries, associates, and holding entities. Total voting turnout reached 76.27% of outstanding shares.
As per the Attachment.
Annual General Meeting · 29 Sept 2026, 11:57 pm
Cian Healthcare Shareholders Approve FY26 Results, Auditor Appointments, and ESOP Scheme 2026 Cian Healthcare Limited concluded its 23rd Annual General Meeting on 29th Sep'26, where shareholders approved all six proposed resolutions with 100% majority of polled votes. Key ordinary approvals included the adoption of standalone and consolidated audited financial statements for the fiscal year ended 31st Mar'26, the re-appointment of Non-Executive Director Pradeep Kumar Jain, and the appointment of M/s Rasool Singhal & Co. as statutory auditors. Shareholders also passed special resolutions authorizing the implementation of the Employee Stock Option Scheme 2026 and extending option grants across group entities.
As per the Attachment.
Others (Uncategorized) · 06 Sept 2026, 1:18 am
Cian Healthcare Dispatches AGM Notice and FY26 Annual Report Access Details Cian Healthcare Limited has dispatched communications to shareholders without registered email addresses, providing access paths and web links to the FY26 Annual Report and the Notice of its 23rd Annual General Meeting. The AGM is scheduled for 29th Sep'26 at 11:00 AM IST via Video Conferencing/Other Audio-Visual Means. In compliance with regulatory guidelines, the company confirmed no physical copies will be dispatched unless specifically requested, and reminded shareholders to complete mandatory PAN, KYC, and bank detail registrations to receive electronic corporate payouts.
As per the Attachment.
Annual General Meeting · 04 Sept 2026, 10:49 pm
Cian Healthcare Announces 23rd AGM, Auditor Appointment, and ESOS 2026 Cian Healthcare scheduled its 23rd AGM for 29th Sep'26 via VC/OAVM, with remote e-voting running from 26th Sep'26 to 28th Sep'26 and a cut-off date of 24th Sep'26. Key agenda items include adopting FY26 financial statements, re-appointing Non-Executive Director Pradeep Kumar Jain, and appointing M/s Rasool Singhal & Co. as Statutory Auditors for five years at an annual fee of INR 6.00 lakh. The board also seeks shareholder approval for ESOS 2026, granting up to 1.00 crore stock options to eligible employees.
The Annual Report for the Financial Year 2025-26 and Notice of the 23rd (Twenty-Third) Annual General Meeting (''AGM'') of the Company.
Others (Uncategorized) · 04 Sept 2026, 9:45 pm
As per the Attachment
Outcome · 02 Sept 2026, 10:39 pm
Cian Healthcare Approves 10M Share ESOP and Announces Auditor Changes On 2nd Sep'26, Cian Healthcare’s Board approved the Employee Stock Option Scheme 2026, authorizing up to 10,000,000 options convertible into equity shares, subject to shareholder approval. The ESOP features a minimum one-year vesting and a five-year exercise period. The Board also appointed Rasool Singhal & Co. as Statutory Auditors to fill a casual vacancy following the previous auditor's resignation. Furthermore, N D M & Company was appointed as Internal Auditors for FY27. The company's upcoming AGM is scheduled for 29th Sep'26.
As per the Attachment.
Change in Auditor · 02 Sept 2026, 10:33 pm
Cian Healthcare Audit Committee Reviews Statutory Auditor Resignation Cian Healthcare's Audit Committee convened on 2nd Sep'26 to review the resignation of statutory auditors M/s S S R C A & Co., which took effect on 27th Aug'26. The Committee formally confirmed the absence of any audit qualifications, underlying financial concerns, or undisclosed material reasons driving the resignation, beyond those explicitly stated in the auditor's formal resignation letter. The committee's views have been forwarded to the Board of Directors for final noting, indicating no underlying financial irregularities prompted the auditor's departure.
Please find attached the disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015.
Change in Auditor · 28 Aug 2026, 12:32 am
Cian Healthcare's Statutory Auditor Resigns Citing Professional Commitments M/s. SSRCA & Co. have resigned as the statutory auditors of Cian Healthcare Limited (CHCL) effective 27 Aug'26. The resignation is attributed to "professional commitments and pre-occupations." SSRCA & Co. confirmed there are no other material reasons for their departure. The firm was originally appointed on 10 Jan'25 for a term ending 09 Jan'29. The company's Audit Committee will disclose its views on the resignation in its forthcoming meeting. The auditor's last submitted report was for the financial year ended 31 Mar'26.
As per the Attachment
Others (Uncategorized) · 22 Aug 2026, 4:26 pm
BSE Revises Market Lot for Cian Healthcare Following its NCLT-approved resolution plan, Cian Healthcare's market lot size has been revised by the BSE. Effective from 24 Aug'26, the trading lot will be reduced from 2,000 equity shares to 137 shares. This change follows the recommencement of trading approval granted on 30 Mar'26 for 2.5 crore new equity shares issued under the resolution plan. The adjustment stems from the NCLT order dated 18 Dec'25. This revision may improve liquidity and accessibility for retail investors.
As per the attachment.
Change in Management · 04 Jul 2026, 10:49 pm
Cian Healthcare's Internal Auditors Resign Effective 4th Jul'26 Cian Healthcare (CHCL) announced the resignation of its internal auditors, M/s. Chirag Sancheti and Associates, effective 4th Jul'26. The resignation is attributed to the audit firm's prior professional commitments and pre-occupations which prevent them from dedicating the required time and resources. The outgoing auditors confirmed completion of the internal audit for FY26 and will ensure a seamless handover to their successor. This change in a key oversight function warrants investor attention pending the appointment of a new internal auditor.
As per the Attachment
Outcome · 30 May 2026, 11:58 pm
Cian Healthcare Board Seeks Shareholder Approval for Major Resolutions Cian Healthcare's board, in its meeting on 30 May'26, approved seeking shareholder approval via postal ballot for several key proposals. These include material related party transactions with promoters Pradeep Kumar Jain, Rajesh Jain, and holding company Ananta Medicare Ltd. The board is also seeking approval to enhance borrowing limits, sell or lease the company's undertaking, and expand limits for loans, guarantees, and investments. Additionally, the re-appointment of Rajesh Jain as MD and appointment of Simmi Soni as Woman Non-Executive Director are proposed.
Cian Healthcare Limited, in its board meeting dated May 30, 2026, has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact ....
Financial Result · 30 May 2026, 11:49 pm
Cian Healthcare Reports Audited FY26 Results with Qualified Audit Opinion Cian Healthcare's board approved audited standalone and consolidated results for the year ended 31 Mar '26. On a consolidated basis, the company reported total income of ₹2,946.87 lakhs and a net loss after tax of ₹2,329.27 lakhs. The statutory auditor, SSRCA & Co., issued a qualified opinion on the financial statements. Key qualifications include the inability to verify balances of trade receivables, inventory valuation differences of ₹1,353.73 lakhs, and inadequate supporting documentation for Property, Plant & Equipment, GST balances, and internal financial controls.
Outcome of the Board Meeting of Cian Healthcare Limited held on May 30, 2026- Audited Financial Results (Standalone and Consolidated) for the half-year and Financial Year ended March 31, 2026.
Outcome · 30 May 2026, 11:33 pm
Cian Healthcare Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 1,698 (+42.6% YoY | +49.9% QoQ) ■ EBITDA: -302 (+42.8% YoY | +22.7% QoQ) ■ EBITDA Margin (%): -17.8 (+2657 bps YoY | +1672 bps QoQ) ■ PAT: -1,797 (-132.6% YoY | -237.7% QoQ) ■ EPS (INR): -7.19 (-132.7% YoY | -237.6% QoQ)
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Intimation · 30 May 2026, 5:30 am
Cian Healthcare Board to Approve FY26 Financial Results on May 30 Cian Healthcare Limited has scheduled a Board of Directors meeting for Saturday, May 30, 2026. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the half-year and financial year ended Mar 31, 2026. The trading window for designated persons has been closed since Apr 01, 2026, and will reopen 48 hours after the results are declared.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 20 Apr 2026, 4:52 pm
Cian Healthcare Confirms Non-Applicability of Large Corporate Framework Cian Healthcare Ltd. (BSE: 542678) has informed exchanges that it does not meet the criteria to be classified as a Large Corporate as of 31st Mar'26. The determination is based on SEBI circulars regarding fund-raising via debt securities. Consequently, the disclosure and compliance requirements mandated for Large Corporates are not applicable to the company. This confirmation stems from its outstanding borrowing of ₹13.55 crore as of Mar'26 and having no credit rating during the previous financial year.
As per the Disclosure attached.
Others (Uncategorized) · 31 Mar 2026, 5:17 pm
Cian Healthcare Receives BSE Trading Approval for 2.5 Crore Equity Shares Cian Healthcare received trading approval from BSE on 30 Mar'26 for 2.50 crore new equity shares with a face value of INR 10/- each, pursuant to its NCLT-approved Resolution Plan dated 18 Dec'25. This includes 12.50 lakh shares allotted to public shareholders and 2.375 crore shares allotted to promoters. The newly issued shares will be admitted for trading on the BSE effective 02 Apr'26, concluding a key step in the company's resolution process under the Insolvency and Bankruptcy Code.
As per the attachment.
Others (Uncategorized) · 21 Mar 2026, 7:09 pm
Cian Healthcare Gets BSE Nod to List 2.375 Cr Preferential Shares Cian Healthcare (CHCL) has received BSE listing approval for 2.375 crore fully paid-up equity shares of INR 10 each, issued on a preferential basis to its promoters. This action stems from a Resolution Plan approved by the NCLT on 18 Dec'25. The promoters receiving the shares are Ananta Medicare Limited (55%), Mr. Rajesh Jain (21%), and Mr. Pradeep Kumar Jain (19%). Trading approval is contingent upon completing further formalities with depositories. The total aggregate value of the issuance is INR 23.75 crores.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Jain
Others (Uncategorized) · 18 Mar 2026, 8:56 pm
Rajesh Jain and PACs Acquire 95% Stake in Cian Healthcare Rajesh Jain, along with Persons Acting in Concert (PACs), acquired a 95% stake in Cian Healthcare Ltd. The acquisition was executed on 16-Mar'26 via an allotment of 2.375 crore equity shares pursuant to a Resolution Plan approved by the NCLT on 18-Dec'25. Post-transaction, Rajesh Jain holds a 21% stake, while PACs Ananta Medicare Ltd and Pradeep Kumar Jain hold 55% and 19% respectively. The acquisition, valued at INR 5.25 crore for Rajesh Jain's portion, is exempt from open offer requirements.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ananta Medicare Ltd
Others (Uncategorized) · 18 Mar 2026, 8:50 pm
Ananta Medicare Acquires 55% Stake in Cian Healthcare Ananta Medicare Ltd has acquired 1,37,50,000 equity shares of Cian Healthcare Ltd, representing a 55% stake. The acquisition, valued at INR 13.75 crore, was completed on 16 Mar'26. This transaction is part of a Resolution Plan approved by the NCLT on 18 Dec'25. Along with persons acting in concert (Rajesh Jain and Pradeep Kumar Jain), the total acquisition amounts to a 95% stake in Cian Healthcare. The acquisition is exempt from open offer requirements under SEBI regulations.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Jain
Others (Uncategorized) · 18 Mar 2026, 8:46 pm
Promoter Group Acquires 95% Stake in Cian Healthcare Acquirer Pradeep Kumar Jain, along with persons acting in concert (Rajesh Jain, Ananta Medicare Limited), has acquired a 95% stake in Cian Healthcare Limited. The acquisition of 2,37,50,000 shares was made via an allotment on 16-Mar'26, pursuant to a Resolution Plan approved by the NCLT on 18-Dec'25. Post-transaction, Pradeep Kumar Jain holds 19%, Rajesh Jain holds 21%, and Ananta Medicare Limited holds 55%. The acquisition is exempt from an open offer under SEBI regulations.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Jain & PACs
Acquisition/ Disposal of Shares · 17 Mar 2026, 10:44 pm
Promoter Group Acquires 95% Stake in Cian Healthcare Rajesh Jain, along with Persons Acting in Concert (PACs), acquired a 95% stake in Cian Healthcare on 16 Mar'26. The acquisition of 2.375 Cr shares was via a preferential allotment under a National Company Law Tribunal-approved resolution plan from 18 Dec'25. Post-acquisition, the acquirer group, which belongs to the promoter group, holds 2.375 Cr shares. This increased Cian's total equity share capital from INR 1.25 Cr to INR 25 Cr. Rajesh Jain individually acquired 52.5 lakh shares, representing a 21% stake.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Kumar Jain & PACs
Acquisition/ Disposal of Shares · 17 Mar 2026, 10:29 pm
Promoter Group Acquires 95% Stake in Cian Healthcare Promoter Pradeep Kumar Jain and Persons Acting in Concert (PACs) acquired 2,37,50,000 equity shares of Cian Healthcare on 16 Mar'26 via a preferential allotment. This acquisition, part of a Resolution Plan approved by the NCLT on 18 Dec'25, increased the promoter group's total holding to 95%. Pradeep Kumar Jain acquired 47,50,000 shares (19% stake), and PACs acquired 1,90,00,000 shares (76% stake). Post-acquisition, the company's total paid-up equity share capital increased to INR 25.00 crore.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ananta Medicare Ltd & PACs
Acquisition/ Disposal of Shares · 17 Mar 2026, 8:19 pm
Ananta Medicare Acquires Controlling Stake in Cian Healthcare Ananta Medicare Limited acquired 1.37 crore equity shares of Cian Healthcare on 16 Mar'26, pursuant to a resolution plan approved by the NCLT on 18 Dec'25. This acquisition gives Ananta a 55% stake in Cian Healthcare. Including Persons Acting in Concert (PACs), who acquired 1.00 crore shares (40%), the total promoter group holding now stands at 95%. Post-acquisition, Cian Healthcare's equity share capital increased from INR 1.25 crore to INR 25.00 crore, while total diluted shares rose to 2.50 crore.
as per the attachment
Others (Uncategorized) · 16 Mar 2026, 11:52 pm
Cian Healthcare Board Approves Revised Code for UPSI Disclosure Cian Healthcare's Board of Directors, in its meeting on 16 Mar'26, approved a revised "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information" (UPSI). This procedural update, made pursuant to SEBI's Insider Trading Regulations, refines the framework for handling and disseminating UPSI to ensure regulatory compliance, timely disclosure, and fair dealing with stakeholders. The updated code is effective immediately and aims to prevent the misuse of sensitive information and maintain market integrity for the company's securities (BSE: 542678).